Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
04 April 2018 Photo SASCOC
Large Kovsie contingent at Commonwealth Games
Elmé de Villiers (badminton) is one of several former or current Kovsies who will be in action at the Commonwealth Games between 5 and 15 April.
The University of the Free State (UFS) will be well represented at the Commonwealth Games with 11 current or former Kovsies participating in Australia.

The Games take place from 5 to 15 April on the Gold Coast. For many of the sporting codes, this is the second biggest sporting stage after the Olympic Games.

The eight athletes are Ts’epang Sello, Juanelie Meijer and Karla Pretorius (current students) and former Kovsies Juanré Jenkinson, Elmé de Villiers, Nicole Walraven, Maryka Holtzhausen and Philip Snyman. 

In addition, three members of the management team, Neil Powell, Kate Roberts and Jan Wahl, all previously studied at the UFS. 

Holtzhausen and Powell at their third Games 
Sello will be competing in the 800m in the colours of Lesotho, her country of birth. 

Pretorius is the vice-captain of the netball team and Holtzhausen was the former captain before her serious injury in 2016. Pretorius is doing a postgraduate in Dietetics and Holtzhausen is a contract worker at Kovsiesport. She will be competing at her third Games. 
De Villiers is a member of the South African badminton team and Walraven is with the Protea hockey team. Snyman will captain the rugby team.

Meijer (long jump) and Jenkinson (shot put) will battle in the para-athletic programme.

Powell will coach the Blitzbokke who are the defending champions from 2014. It will be his second Games in charge. He also won the bronze medal as a player in 2010. 

Roberts is the manager of the triathlon team and a participant in 2006. Wahl will act as the manager of the para-athletics team.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept